Melatonin in cancer patients and in tumor-bearing animals

Advances in Experimental Medicine and Biology

Volumn 467, Issue , 2000, Pages 247-264

  Bartsch, C ^a   Bartsch, H ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GROWTH HORMONE; INDOLEAMINE 2,3 DIOXYGENASE; MELATONIN; PROLACTIN; SEROTONIN N ACETYLTRANSFERASE; THYROTROPIN; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR MARKER;

ADENOCARCINOMA; BREAST CANCER; CANCER PATIENT; CARCINOSARCOMA; CIRCADIAN RHYTHM; CONFERENCE PAPER; DOWN REGULATION; HORMONE DEFICIENCY; HORMONE METABOLISM; IMMUNE SYSTEM; MESENCHYME; MYOEPITHELIUM CELL; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; OVARY CANCER; PINEAL BODY; PRIORITY JOURNAL; PROSTATE CANCER; SARCOMA; SYMPATHETIC TONE; TUMOR VOLUME;

ANIMALS; FEMALE; HUMANS; MALE; MELATONIN; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PINEAL GLAND; RATS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0034466534     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (71)

1. Radioimunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer
2. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats
3. Melatonin and colon carcinogenesis. II. Intestinal melatonin-containing cells and serum melatonin level in rats with 1,2-dimethylhydrazine-induced colon tumors
4. Melatonin assays in body fluids
5. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: Abolition of the urinary 24-hour rhythm with atenolol
6. A study of the pineal hormone melatonin as a second line therapy in metastatic colorectal cancer resistant to fluorouracil plus folates
7. Role of pinealectomy on Walker 256 carcinoma in rats
8. Urinary melatonin levels in human breast cancer patients
9. Serum melatonin and cortisol rhythms of patients with benign and malignant tumours of the prostate
10. Circadian rhythms of serum melatonin, prolactin and growth hormone in patients with benign and malignant tumors of the prostate and in non-tumor controls
11. Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: Relationship with the pituitary hormones
12. Melatonin rhythms in prostate cancer patients: Effect of operation and hormone treatment
13. Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors
14. Pineal melatonin synthesis and secretion during induction and growth of mammary cancer in female rats
15. Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism
16. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: Evidence for reduced pineal activity and relevance of urinary determinations
17. Melatonin secretion in oncological patients: Current results and methodological considerations
18. Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients. Consequence of premature aging or of tumor growth?
19. Serial transplants of DMBA-induced mammary tumors in Fischer rats as model system for human breast cancer. IV. Parallel changes of biopterin and melatonin indicate interactions between the pineal gland and cellular immunity in malignancy
20. Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size
21. Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer
22. Prostate cancer and tumor stage-dependent circadian neuroendocrine disturbances
23. Serial transplants of DMBA-induced mammary tumors in Fischer rats as a model system for human breast cancer. VI. The role of different forms of tumor-associated stress for the regulation of pineal melatonin secretion
24. Serial transplants of DMBA-induced mammary tumors in Fischer rats as model system for human breast cancer. V. Myoepithelial-mesenchymal conversion during passaging as possible cause for modulation of pineal-tumor interaction
25. Effect of melatonin on experimental tumors under different photoperiods and times of administration
26. The relationship between the pineal gland and cancer: Seasonal aspects
27. Differential effect of melatonin on early and advanced passages of a DMBA-induced mammary carcinoma in the female rat
28. Seasonality of pineal melatonin production in the rat: Possible synchronization by the geomagnetic field
29. Über den einflu von zirbelextrakten auf tumoren bei weien mäusen und bei menschen
30. Melatonin in human preovulatory follicular fluid
31. Neural-hormonal integrative mechanisms in the pineal gland and superior cervical ganglia
32. Changes in hormonal and biochemical parameters in gastric adenocarcinoma
33. Plasma melatonin and the hormone-dependency of human breast cancer
34. Wachstumsbeeinflussende hormone und tumorwachstum
35. Immunochemical evidence for increased titers of liver pyrrolase during substrate and hormonal enzyme induction
36. Interplay between sex steroids and melatonin in regulation of human benign prostate epithelial cell growth
37. Growth factors and cancer
38. A significant correlation between melatonin deficiency and endometrial cancer
39. 24-h-melatonin-serumprofile bei mammakarzinom- patientinnen im vergleich zu einer tumorfreien kontrollgruppe
40. Versuche der postoperativen krebsbehandlung mit zirbelstoffen
41. Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumor
42. Detection of melatonin and serotonin N-acetyltransferase and hydroxyindole-O-methyltransferase activities in rat ovary
43. Metabolism of exogenous melatonin in schizophrenic and non-schizophrenic volunteers
44. Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans
45. Serial transplants of 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Fischer rats as model system for human breast cancer. 3. Quantitative ultrastructural studies of the pinealocytes and plasma melatonin concentrations in rats bearing an advanced passage of the tumor
46. Serum melatonin circadian profile in women with adenocarcinoma of uterine corpus
47. Hormones and cancer in humans
48. Plasma melatonin levels in patients suffering from colorectal carcinoma
49. Photoneural regulation of the mammalian pineal gland
50. Daily excretion of melatonin in patients with cancer of the stomach and large intestine
51. Twenty-four-hour rhythms in relation to the natural photoperiod: A field study in humans
52. Influence of simultaneous pinealectomy and thymectomy on the growth and formation of metastases of the Yoshida sarcoma in rats
53. Effects of growing tumours on pineal melatonin levels in male rats
54. Effect of ovariectomy on serially transplanted rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene
55. Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: Its efficacy in preventing hypotension
56. Effects of low-dose recombinant interleukin-2 in human malignancies
57. The immunoneuroendocrine role of melatonin
58. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion
59. Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase activity
60. Melatonin receptors: Localization, molecular pharmacology and physiological significance
61. Inhibition of Dunning tumor growth by melatonin
62. The aetiology and pathogenesis of prostate cancer
63. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods
64. 6-Sulphatoxymelatonin production in breast cancer patients
65. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in the rat
66. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer
67. Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man
68. Melatonin and steroids in human pre-ovulatory follicular fluid: Seasonal variations and granulosa cell steroid production
69. Overview superoxygenase